Cardiogen Bioregulator Peptide 🜃 Khavinson's “Heart Rejuvenation Peptide”

[00:00:00]For decades, your doctor has been working from a single assumption about your heart. Once it's damaged, it stays damaged. A heart attack leaves scar tissue. That scar tissue doesn't become muscle again. You manage the symptoms.

[00:00:13]You take the medications. You accept the new ceiling. That has been the foundational belief of mainstream cardiology for as long as most of us have been alive. And then 42 patients walked into a clinical trial in Russia.

[00:00:27]All of them diagnosed with ischemic heart disease. All of them already on conventional cardiac therapy. Half of them received something additional alongside their standard treatment. One of Khavinson's hidden by regulators.

[00:00:39]Four amino acids. Alanine, glutamic acid, aspartic acid, arginine. That's it. By the end of the trial, that group was experiencing significantly fewer angina attacks. Their exercise tolerance had climbed. Their ECG results showed measurable efficiency improvements. And over half of them had cut their nitrate medication dosage in half. Not because someone told them to. Because their hearts no longer needed it at the same level. The tissue had changed. The organ had responded. The ceiling had been moved. The peptide is called cardiogen.

[00:01:16]And the reason it produced those results is not a mystery. At the cellular level, cardiogen is doing something that no conventional cardiac drug attempts. It's rebuilding the structural scaffolding of heart cells from the inside out.

[00:01:30]Boosting actin for cell migration and wound healing. Up-regulating tubulin and vimentin for structural cardiomyocyte integrity. And going even deeper into the cell nucleus to strengthen the nuclear lamina through lamin A and lamin C up-regulation. It is supporting and protecting the DNA.

[00:01:49]Protecting heart cells from the programmed death that conventional cardiology says is inevitable. This is not symptom management. This is structural cardiac regeneration. And there is one more finding from the research on Cardiogen that I genuinely did not expect and that will change the way you think about what these peptides are actually capable of. But we'll get into that in just a moment. Some of the other benefits of Cardiogen are its ability to reduce mortality by a factor of three in rodents with myocardial infarction.

[00:02:20]And it was also able to stimulate myocardial glucose utilization and reduce the necrotized tissue in the heart by significantly decreasing necrosis in the myocardium.

[00:02:30]It was also shown in one human study to slightly raise blood potassium levels, similarly to how Celloheart does. Before we go any further, this video is part of the first full playlist ever made about 44 of Khavinson's hidden bioregulators.

[00:02:46]I've read thousands of scientific papers and over 50 years worth of research, most of it buried in obscure Russian journals the Western world never translated. Even billionaire-funded longevity labs are only just now finding out the breakthroughs that Khavinson proved decades ago. At the Peptide Science Institute, we're bringing Khavinson's research to the West and showing the world the incredible transformations bioregulators, bioaugmenters, and our precision cell method can create. If you know anyone who would be interested in the power of these hidden bioregulators, share this playlist with them. Spread the magic, move the world. And as a thank you, we'll send you the magic of Khavinson's hidden bioregulators for free. Link in the description. And Cardiogen also has demonstrated the ability to inhibit tumor growth in a preclinical rat model of M-1 sarcoma, where it caused the tumor cells to die.

[00:03:34]And this is also where you need to understand how to actually think about results like this because what Cardiogen is doing mechanistically fits directly into what we call the precision cell method.

[00:03:44]It's targeting the heart tissue itself, the cardiomyocytes, the structural proteins, the nuclear integrity of the cells that make up the myocardium. And that's why you see changes in things like necrosis and oxygen utilization, the actual functional output improving.

[00:04:00]But, and this is very critical, that does not mean that Cardiogen on its own rebuilds the heart in every scenario.

[00:04:07]Because ischemic heart disease is but one condition that affects the heart.

[00:04:12]And there are multiple layers to it considering the root cause, you know, from autoimmune diseases, uh medication-induced nutrient deficiencies, and just unoptimal uh medications and supplementations, as well.

[00:04:27]And if those layers aren't being addressed simultaneously, then improving the structure of the heart cells alone will only take you so far.

[00:04:36]So, what Cardiogen is doing is targeting one of the deepest layers of the problem, the structural and cellular integrity of the heart itself.

[00:04:44]And when that layer is combined with the rest of the system being optimized, then that's when you really start to see the kind of outcomes that shift medication requirements long-term, and also improve things like exercise tolerance, and greatly improve the state of the patient to such a degree that you may be surprising your doctor.

[00:05:09]And that's what actually moves the ceiling we talked about earlier.

[00:05:13]So, in the only human clinical trial of Cardiogen, it was dosed at one to two capsules one to two times daily.

[00:05:21]And I would also like to note that the dose per capsule was 100 micrograms.

[00:05:27]However, you may hear others claiming the dose per capsule to be anywhere from 20 mg to 215 mg. However, that is just not true.

[00:05:35]At least with the brands that exist on the market at the time of this video.

[00:05:39]And if you'd like to learn more about Cardiogen, including dosages that you may be able to use for subcutaneous injections, or even potentially through the intranasal route and some other things which are not used in a clinical fashion with cardiogen but are theoretically plausible and the dosages we can sort of extrapolate from other common sense peptides and research on them then you may want to get our book Peptide Salvation. The link is in the description.

[00:06:13]This has been Brandon Henry one of the founders of the Peptide Science Institute and thank you so much for watching.